Corporate Social Responsibility in Global Value Chains: Where Are We Now and Where Are We Going?

被引:199
|
作者
Lund-Thomsen, Peter [1 ]
Lindgreen, Adam [2 ]
机构
[1] Copenhagen Business Sch, Ctr Corp Social Responsibil, DK-2000 Frederiksberg, Denmark
[2] Cardiff Univ, Cardiff Business Sch, Cardiff CF10 3EU, S Glam, Wales
关键词
Compliance paradigm; Cooperative paradigm; Corporate social responsibility; Global value chains; PRODUCTION NETWORKS; LABOR STANDARDS; WORK CONDITIONS; CUT FLOWER; ORGANIZATION; CSR; GLOBALIZATION; PERSPECTIVES; GOVERNANCE; MOVEMENT;
D O I
10.1007/s10551-013-1796-x
中图分类号
F [经济];
学科分类号
02 ;
摘要
We outline the drivers, main features, and conceptual underpinnings of the compliance paradigm. We then use a similar structure to investigate the drivers, main features, and conceptual underpinnings of the cooperative paradigm for working with CSR in global value chains. We argue that the measures proposed in the new cooperation paradigm are unlikely to alter power relationships in global value chains and bring about sustained improvements in workers' conditions in developing country export industries. After that, we provide a critical appraisal of the potential and limits of the cooperative paradigm, we summarize our findings, and we outline avenues for research: purchasing practices and labor standard noncompliance, CSR capacity building among local suppliers, and improved CSR monitoring by local resources in the developing world.
引用
收藏
页码:11 / 22
页数:12
相关论文
共 50 条
  • [41] Measuring vaccination coverage - Where are we now and where are we going?
    Shefer, Abigail
    Santoli, Jeanne
    Singleton, James A.
    [J]. JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE, 2007, 13 (06): : 541 - 543
  • [42] Intrahepatic Cholangiocarcinoma-Where Are We Now and Where Are We Going to?
    Wasilewicz, Michal P.
    Becht, Rafal
    [J]. MEDICINA-LITHUANIA, 2023, 59 (04):
  • [43] Retirement income in America: Where are we now and where are we going?
    Salisbury, DL
    [J]. RETIREMENT PROSPECTS IN A DEFINED CONTRIBUTION WORLD, 1997, : 11 - 20
  • [44] Molecular Pathology in Therapeutics: Where are We Now, and Where are We Going?
    Harrison, David J.
    Faratian, Dana
    [J]. CURRENT DRUG TARGETS, 2012, 13 (12) : 1473 - 1474
  • [45] Treating Lupus in the Kidney: Where Are We Now, and Where Are We Going?
    Canetta, Pietro A. A.
    Bomback, Andrew S.
    Radhakrishnan, Jai
    [J]. DISCOVERY MEDICINE, 2011, 12 (65) : 341 - 349
  • [46] Genetics of Pancreatic Cancer: Where Are We Now? Where Are We Going?
    Del Chiaro, Marco
    Boggi, Ugo
    Presciuttini, Silvano
    Bertacca, Laura
    Croce, Chiara
    Mosca, Irene
    Mosca, Franco
    [J]. JOURNAL OF THE PANCREAS, 2005, 6 (01): : 60 - 67
  • [47] Obamacare in the Trump Era: Where are we Now, and Where are we Going?
    Beland, Daniel
    Rocco, Philip
    Waddan, Alex
    [J]. POLITICAL QUARTERLY, 2018, 89 (04): : 687 - 694
  • [48] Awake spinal surgery: where we are now and where we are going
    Ray, Wilson Z.
    Falavigna, Asdrubal
    Mummaneni, Praveen V.
    Bucelli, Robert C.
    [J]. NEUROSURGICAL FOCUS, 2021, 51 (06)
  • [49] Where are we now, and where are we going? Perspectives on cosmic abundances
    Beers, TC
    [J]. COSMIC ABUNDANCES AS RECORDS OF STELLAR EVOLUTION AND NUCLEOSYNTHESIS IN HONOR OF DAVID L. LAMBERT, 2005, 336 : 283 - 288
  • [50] Information technology and productivity: Where are we now and where are we going?
    Oliner, SD
    Sichel, DE
    [J]. TECHNOLOGY, GROWTH, AND THE LABOR MARKET, 2003, : 41 - 94